Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples